Artificial Intelligence for the Molecular Diagnosis of Kidney Diseases: From Computational Pathology to Noninvasive Multi-Omics

Creatinine, estimated glomerular filtration rate and histology detect kidney disease late and say little about the molecular heterogeneity driving progression. Artificial intelligence can extract molecular features from biofluid omics; digitised biopsies and retinal images supply proxy readouts, not molecular measurements. In this review we grouped the literature by histopathology, multi-omics, foundation models and noninvasive systems and checked each result against its cohort, endpoint and validation setting. Reported performance is often high, but most results come from retrospective single-cohort evaluations; external and prospective validation are uncommon, and we found no study among those reviewed showing improved patient outcomes. High discrimination therefore establishes technical performance only; clinical utility and patient benefit remain untested. The evidence to date supports feasibility, not benefit, and the weakness lies in evaluation design rather than model architecture. The evidence so far establishes feasibility, not benefit. Until prospective studies on shared external cohorts are available, these tools are best used to augment existing diagnostic practice, with patient outcomes as the measure of success.

Authors

Institutions

Publication Details

Journal
Bioengineering
Published
2026-11-18
DOI
https://doi.org/10.3390/bioengineering13111380
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial Intelligence for the Molecular Diagnosis of Kidney Diseases: From Computational Pathology to Noninvasive Multi-Omics

Jiefei Zeng, Huiming Wang, Huapan Shu
1 links
Bioengineering
Artificial Intelligence in Healthcare and Education
article

Artificial Intelligence for the Molecular Diagnosis of Kidney Diseases: From Computational Pathology to Noninvasive Multi-Omics

Jiefei Zeng, Huiming Wang, Huapan Shu
article en

Abstract

Creatinine, estimated glomerular filtration rate and histology detect kidney disease late and say little about the molecular heterogeneity driving progression. Artificial intelligence can extract molecular features from biofluid omics; digitised biopsies and retinal images supply proxy readouts, not molecular measurements. In this review we grouped the literature by histopathology, multi-omics, foundation models and noninvasive systems and checked each result against its cohort, endpoint and validation setting. Reported performance is often high, but most results come from retrospective single-cohort evaluations; external and prospective validation are uncommon, and we found no study among those reviewed showing improved patient outcomes. High discrimination therefore establishes technical performance only; clinical utility and patient benefit remain untested. The evidence to date supports feasibility, not benefit, and the weakness lies in evaluation design rather than model architecture. The evidence so far establishes feasibility, not benefit. Until prospective studies on shared external cohorts are available, these tools are best used to augment existing diagnostic practice, with patient outcomes as the measure of success.

BioengineeringVol. 13(11)
Zhongnan Hospital of Wuhan University (CN), Renmin Hospital of Wuhan University (CN)
National Natural Science Foundation of China
Good health and well-being
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon